Late-stage diversification of rewired purine C-nucleosides reveals potent antitrypanosomatid agents with in vivo efficacy
Bron
Journal of medicinal chemistry - ISSN 0022-2623-69:16 (2026) p. 19744-19758
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 1: setting the stage
Bron
The journal of antimicrobial chemotherapy - ISSN 0305-7453-81:5 (2026) p. 1-5
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate
Bron
The journal of antimicrobial chemotherapy - ISSN 0305-7453-81:6 (2026) p. 1-10
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit
Bron
The journal of antimicrobial chemotherapy - ISSN 0305-7453-81:4 (2026) p. 1-14
Discovery of a series of macrocycles as potent inhibitors of Leishmania infantum
Bron
Journal of medicinal chemistry - ISSN 0022-2623-67:20 (2024) p. 18170-18193